Novo Nordisk sues pharmacies over impure Wegovy, Ozempic dupes
WEARVALLEYMERCURY
A 0.25 mg injection pen of Novo Nordisk’s weight reduction drug Wegovy is proven on this picture in Oslo, Norway, on Aug. 31, 2023. Victoria Klesty | Reuters Novo Nordisk on Thursday mentioned it sued two compounding pharmacies in Florida for allegedly promoting impure and “probably unsafe” medication claiming to include semaglutide, the energetic ingredient … Read more